Hepion Pharmaceuticals (HEPA)
NASDAQ:HEPA
Holding HEPA?
Track your performance easily

Hepion Pharmaceuticals (HEPA) Financial Statements

699 Followers

Hepion Pharmaceuticals Financial Overview

Hepion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-6.405; its P/E ratio is -0.11; Hepion Pharmaceuticals is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.93M$ -5.18M$ -11.43M$ -10.52M$ -14.08M
EBITDA$ -3.93M$ -5.15M$ -11.42M$ -10.51M$ -14.06M
Net Income Common Stockholders$ -3.93M$ -2.85M$ -11.06M$ -10.53M$ -14.08M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.12M$ 13.11M$ 14.79M$ 19.28M$ 30.52M
Total Assets$ 6.01M$ 15.99M$ 18.09M$ 25.00M$ 36.50M
Total Debt$ 154.09K$ 175.27K$ 209.02K$ 241.54K$ 0.00
Net Debt$ -1.96M$ -12.93M$ -14.58M$ -19.04M$ -30.52M
Total Liabilities$ 2.45M$ 8.47M$ 10.81M$ 8.84M$ 10.13M
Stockholders Equity$ 3.56M$ 7.52M$ 7.28M$ 16.16M$ 26.37M
Cash Flow-
Free Cash Flow$ -10.90M$ -3.60M$ -9.00M$ -11.20M$ -12.52M
Operating Cash Flow$ -10.90M$ -3.60M$ -9.00M$ -11.20M$ -12.50M
Investing Cash Flow$ -2.02M-$ -348.00$ 2.58K$ -16.54K
Financing Cash Flow-$ 1.85M$ 4.49M--
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Hepion Pharmaceuticals Debt to Assets

Hepion Pharmaceuticals Cash Flow

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis